Published in Open Med on December 04, 2007
Current trends in the management of gastroesophageal reflux disease: a review. ISRN Gastroenterol (2012) 0.95
Randomized clinical trial: effect of the 5-HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment. Neurogastroenterol Motil (2014) 0.78
Does the evidence show that prokinetic agents are effective in healing esophagitis and improving symptoms of GERD? Open Med (2007) 0.76
Scintigraphic scoring system for grading severity of gastro-esophageal reflux on 99mTc sulfur colloid gastro-esophageal reflux scintigraphy: A prospective study of 39 cases with pre and post treatment assessment. Indian J Nucl Med (2013) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35
Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest (2006) 4.77
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess (1999) 4.45
Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol (2005) 3.86
Heartburn treatment in primary care: randomised, double blind study for 8 weeks. BMJ (1999) 2.44
Cisapride and fatal arrhythmia. N Engl J Med (1996) 2.00
Cisapride-induced torsades de pointes. J Cardiovasc Electrophysiol (1998) 1.60
The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol (2002) 1.45
Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev (2006) 1.10
Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial. Gut (1988) 1.06
Cimetidine and metoclopramide in oesophageal reflux disease. Br Med J (Clin Res Ed) (1983) 1.04
Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial. Dis Esophagus (2004) 1.01
Treatment of severe reflux esophagitis with cimetidine and metoclopramide. Ann Intern Med (1986) 0.94
Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a double-blind trial. Am J Gastroenterol (1984) 0.94
Reflux esophagitis: effect of oral bethanechol on symptoms and endoscopic findings. Ann Intern Med (1980) 0.92
Cisapride versus placebo in reflux esophagitis. A multicenter double-blind trial. J Clin Gastroenterol (1988) 0.89
Torsade de pointes induced by cisapride/clarithromycin interaction. Ann Pharmacother (1999) 0.89
Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis. Hepatogastroenterology (1987) 0.88
Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study. Am J Gastroenterol (1995) 0.87
Healing of grade-II and III oesophagitis through motility stimulation with cisapride. Digestion (1990) 0.81
Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study. Aliment Pharmacol Ther (2002) 0.81
Combination of ranitidine and cisapride in the treatment of reflux oesophagitis. Eur J Gastroenterol Hepatol (1995) 0.81
Cisapride in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (1993) 0.79
Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst Rev (2003) 0.78
The effects of L-sulpiride on reflux oesophagitis. Drugs Exp Clin Res (1991) 0.77
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet (2008) 13.15
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet (2011) 9.31
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) (2012) 9.25
Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med (2003) 7.32
Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ (2002) 4.70
Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med (2011) 4.59
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58
Evaluating the teaching of evidence-based medicine. JAMA (2002) 4.01
Clinical experts or methodologists to write clinical guidelines? Lancet (2009) 3.91
Interventions to reduce unintended pregnancies among adolescents: systematic review of randomised controlled trials. BMJ (2002) 3.90
GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58
Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev (2002) 3.46
Longer- Versus Shorter-Duration Dual-Antiplatelet Therapy After Drug-Eluting Stent Placement: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 3.41
Patients at the center: in our practice, and in our use of language. ACP J Club (2004) 3.32
Randomized controlled trials of surgical interventions. Ann Surg (2010) 3.30
Naturopathic medicine for the prevention of cardiovascular disease: a randomized clinical trial. CMAJ (2013) 3.25
Tips for learning and teaching evidence-based medicine: introduction to the series. CMAJ (2004) 3.23
The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med (2008) 3.01
Randomized trial of reamed and unreamed intramedullary nailing of tibial shaft fractures. J Bone Joint Surg Am (2008) 3.01
Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med (2011) 2.80
Clinician predictions of intensive care unit mortality. Crit Care Med (2004) 2.65
Cooling for neonatal hypoxic ischemic encephalopathy: do we have the answer? Pediatrics (2007) 2.51
Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev (2002) 2.49
Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol (2003) 2.47
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength. J Clin Epidemiol (2013) 2.46
Evidence based medicine has come a long way. BMJ (2004) 2.42
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol (2008) 2.31
Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med (2010) 2.28
Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol (2006) 2.23
Early stopping of randomized clinical trials for overt efficacy is problematic. J Clin Epidemiol (2008) 2.18
Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med (2015) 2.16
Family impact of child oral and oro-facial conditions. Community Dent Oral Epidemiol (2002) 2.09
Clonidine in patients undergoing noncardiac surgery. N Engl J Med (2014) 2.07
The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study. PLoS One (2011) 2.02
Barriers to participating in an HIV vaccine trial: a systematic review. AIDS (2004) 1.97
Teaching evidence-based complementary and alternative medicine: 1. A learning structure for clinical decision changes. J Altern Complement Med (2002) 1.90
Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med (2005) 1.87
Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology (2011) 1.87
Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise. CMAJ (2013) 1.86
Measuring parental perceptions of child oral health-related quality of life. J Public Health Dent (2003) 1.85
Fiber for the treatment of hemorrhoids complications: a systematic review and meta-analysis. Am J Gastroenterol (2006) 1.83
Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.81
Systematic review of reviews including animal studies addressing therapeutic interventions for sepsis. Crit Care Med (2010) 1.78
Outcome measures for clinical research in sepsis: a report of the 2nd Cambridge Colloquium of the International Sepsis Forum. Crit Care Med (2005) 1.77
Tips for learners of evidence-based medicine: 2. Measures of precision (confidence intervals). CMAJ (2004) 1.76
The MacNew Heart Disease health-related quality of life instrument: a summary. Health Qual Life Outcomes (2004) 1.66
Effect of air filtration systems on asthma: a systematic review of randomized trials. Chest (2002) 1.66
Misunderstandings, misperceptions, and mistakes. ACP J Club (2007) 1.63
Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev (2002) 1.62
Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med (2011) 1.58
How many patients? How many limbs? Analysis of patients or limbs in the orthopaedic literature: a systematic review. J Bone Joint Surg Am (2006) 1.57
A comparison of pain, strength, range of motion, and functional outcomes after hemiarthroplasty and total shoulder arthroplasty in patients with osteoarthritis of the shoulder. A systematic review and meta-analysis. J Bone Joint Surg Am (2005) 1.57
A guide to health measurement. Clin Orthop Relat Res (2003) 1.55
Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev (2002) 1.53
Effect of drug law enforcement on drug market violence: a systematic review. Int J Drug Policy (2011) 1.52
Misunderstandings, misperceptions, and mistakes. Evid Based Med (2007) 1.51
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. J Crit Care (2005) 1.50
Guidelines for anticoagulant use in acute coronary syndromes. Lancet (2008) 1.49
Determining the reporting quality of RCTs in clinical pharmacology. Br J Clin Pharmacol (2004) 1.49
The clinical significance of quality of life assessments in oncology: a summary for clinicians. Support Care Cancer (2006) 1.47
Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology (2014) 1.47
A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity. J Gen Intern Med (2014) 1.46
Patients can provide a valid assessment of quality of life, functional status, and general health on the day they undergo knee surgery. J Bone Joint Surg Am (2008) 1.45
Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev (2002) 1.44
Milk allergy and bottles over the back fence: two single patient trials. Cases J (2008) 1.42
Creating clinical practice guidelines we can trust, use, and share: a new era is imminent. Chest (2013) 1.42
The GRADE approach and Bradford Hill's criteria for causation. J Epidemiol Community Health (2010) 1.42
Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.41
Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study. BMJ Open (2012) 1.38
Study to prospectively evaluate reamed intramedually nails in patients with tibial fractures (S.P.R.I.N.T.): study rationale and design. BMC Musculoskelet Disord (2008) 1.36
Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev (2002) 1.34
How to use an article about genetic association: B: Are the results of the study valid? JAMA (2009) 1.33
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. Arch Intern Med (2008) 1.28
Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. CMAJ (2005) 1.26
Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev (2002) 1.22
How to use an article about genetic association: A: Background concepts. JAMA (2009) 1.21
Interaction of St John's wort with conventional drugs: systematic review of clinical trials. BMJ (2004) 1.17
Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol (2010) 1.17
Barriers to participation in HIV drug trials: a systematic review. Lancet Infect Dis (2006) 1.17
Toward Fairness in Data Sharing. N Engl J Med (2016) 1.14
Integrating values and consumer involvement in guidelines with the patient at the center: article 8 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc (2012) 1.12
Treatment preferences, attitudes toward advance directives and concerns about health care. Humane Med (1991) 1.11
Formatting modifications in GRADE evidence profiles improved guideline panelists comprehension and accessibility to information. A randomized trial. J Clin Epidemiol (2012) 1.11
Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res (2005) 1.10
Symbols were superior to numbers for presenting strength of recommendations to health care consumers: a randomized trial. J Clin Epidemiol (2007) 1.09
Citrus fruit intake and stomach cancer risk: a quantitative systematic review. Gastric Cancer (2008) 1.09
Beyond journal clubs. Moving toward an integrated evidence-based medicine curriculum. J Gen Intern Med (2006) 1.08
[The PSA and the risk of repeating the same mistakes]. Medicina (B Aires) (2013) 1.07
Education, ethics, and end-of-life decisions in the intensive care unit. Crit Care Med (2002) 1.05
Assessing and presenting summaries of evidence in Cochrane Reviews. Syst Rev (2013) 1.05
Citrus fruit intake and pancreatic cancer risk: a quantitative systematic review. Pancreas (2009) 1.03
Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale. BMJ Open (2014) 1.02
Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev (2002) 1.02
Disease-specific education in the primary care setting increases the knowledge of people with chronic obstructive pulmonary disease: a randomized controlled trial. Patient Educ Couns (2009) 1.02